Drugs / COVID19 convalescent plasma infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04535063 | Apr → Dec 2020 | pneumonia | Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID19 convalescent plasma infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04535063 ↗ |
| Route | Intravenous | “intravenous infusion of 300-600 mL of convalescent plasma” NCT04535063 ↗ |